Drug Shortage Report for ACT LATANOPROST/TIMOLOL

Last updated on 2020-03-26 History
Report ID 108027
Drug Identification Number 02436256
Brand name ACT LATANOPROST/TIMOLOL
Common or Proper name ACT-LATANOPROST-TIMOLOL 0.005%
Company Name ACTAVIS PHARMA COMPANY
Market Status MARKETED
Active Ingredient(s) TIMOLOL LATANOPROST
Strength(s) 5MG 50MCG
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 2.5ml
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-03-04
Estimated end date 2020-03-31
Actual end date 2020-03-25
Shortage status Resolved
Updated date 2020-03-26
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-03-26 French Compare
v3 2020-03-26 English Compare
v2 2020-03-06 French Compare
v1 2020-03-06 English Compare